Determination of pindolol in human plasma and urine by high-performance liquid chromatography with ultraviolet detection
- 1 January 1986
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 378 (1) , 163-171
- https://doi.org/10.1016/s0378-4347(00)80709-4
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Study of the bioavailability of pindolol in malabsorption syndromes.British Journal of Clinical Pharmacology, 1984
- Determination of pindolol in human plasma by high-performance liquid chromatography with amperometric detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1984
- Estimation of the absolute oral bioavailability of pindolol by two analytical methodsEuropean Journal of Clinical Pharmacology, 1983
- Differential Pharmacological Properties of β-Adrenoceptor Blocking DrugsJournal of Cardiovascular Pharmacology, 1983
- β-Blocking Agents: Determination of Biological Levels Using High Performance Liquid ChromatographyJournal of Liquid Chromatography, 1981
- Determination of pindolol in biological fluids by an electron-capture gas—liquid chromatographic method on a wall-coated open tubular columnJournal of Chromatography B: Biomedical Sciences and Applications, 1980
- Determination of pindolol in biological fluids by electron-capture GLCJournal of Pharmaceutical Sciences, 1980
- Determination of pindolol in human plasma by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1980
- Pharmacokinetics of pindolol in manEuropean Journal of Clinical Pharmacology, 1974
- A method for the fluorimetric determination of 4-(2-Hydroxy-3-isopropylaminopropoxy)-indole (LB 46), aβ-blocking agent, in plasma and urineCellular and Molecular Life Sciences, 1969